A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2004
11/24/2004	EP1478630A2 Process and intermediates for preparing phenylthiomethyl-thiazoles or -oxazoles
11/24/2004	EP1478624A1 Chemical compounds
11/24/2004	EP1478620A1 Phenethanolamine derivatives for treatment of respiratory diseases
11/24/2004	EP1478613A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benz[a]anthracenes for selective effects on estrogen receptors
11/24/2004	EP1478400A1 Therapy for the treatment of migraine comprising anticonvulsant derivatives and antimigraine agents
11/24/2004	EP1478399A1 Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
11/24/2004	EP1478398A1 New medicinal compositions on the basis of anticholinergic agents and egfr kinase inhibitors
11/24/2004	EP1478396A1 Process for the preparation of a nutrient formulation
11/24/2004	EP1478384A2 Method for increasing the survival of dopamine secreting cells
11/24/2004	EP1478380A2 Use of tyrosine kinase inhibitors for treating cns disorders
11/24/2004	EP1478378A2 Anti-allergic complex molecules
11/24/2004	EP1478371A2 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/24/2004	EP1478368A1 Use of benzothiazepines having activity as inhibitors of ileal bile acid transport for reducing cholesterololemia
11/24/2004	EP1478366A1 Pharmaceutical combinations of cox-2 inhibitors and opiates
11/24/2004	EP1478364A2 Selective antibacterial agents
11/24/2004	EP1478361A2 Arylsulfone derivatives
11/24/2004	EP1478358A1 Aryl ureas with angiogenesis inhibiting activity
11/24/2004	EP1478357A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
11/24/2004	EP1478356A2 Therapeutic compounds
11/24/2004	EP1478355A2 Antitumor compositions containing taxane derivatives
11/24/2004	EP1478353A1 Sustained release pharmaceutical composition
11/24/2004	EP1478328A2 Bioactive keratin peptides
11/24/2004	EP1478242A1 Pet food composition for skin photoprotection
11/24/2004	EP1478233A2 Method for administering glp-1 molecules
11/24/2004	EP1318976B1 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
11/24/2004	EP1307201B1 Selective pde 2 inhibitors, used as medicaments for improving cognition
11/24/2004	EP1305306B1 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
11/24/2004	EP1285000B1 Adnf mixtures for enhancing learning and memory
11/24/2004	EP1272201B1 Use of compatible solutes as substances having free radical scavenging properties
11/24/2004	EP1263747B1 1,5-benzothiazepines and their use as hypolipidaemics
11/24/2004	EP1200406B1 Cyclic amides and imides having selective antagonist activity at alpha-1d adrenergic receptor
11/24/2004	EP1183231B1 Cytofectin dimers and methods of use thereof
11/24/2004	EP1180030B1 Antibacterial compounds
11/24/2004	EP1175214B1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
11/24/2004	EP1098655B1 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers
11/24/2004	EP1007677B1 Protease-related protein
11/24/2004	EP0951481B1 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis
11/24/2004	CN1549824A Peptidic compounds selectively binding to p-selectin
11/24/2004	CN1549823A Production of high molecular mass lectins
11/24/2004	CN1549817A Pyrrolo pyrimidines, process for their preparation, their use and pharmaceutical compositions containing them
11/24/2004	CN1549814A Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004	CN1549809A Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
11/24/2004	CN1549734A Aromatase inhibition to enhance assisted reproduction
11/24/2004	CN1549730A Compositions and methods of using capsid protein from flaviviruses and pestiviruses
11/24/2004	CN1549723A Modified interleukin-1 receptor antagonist (IL-1RA) with reduced immunogenicity.
11/24/2004	CN1549721A Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
11/24/2004	CN1549717A Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, process for producing them and pharmaceutical compositions containing them
11/24/2004	CN1549715A Piperidin-2,6-dione salts and its use in the treatment of stress-related affective disorders
11/24/2004	CN1549714A Aminoisoxazole derivatives active as kinase inhibitors
11/24/2004	CN1549713A Diaryl cycloalkyl derivatives, the use thereof as PPAR activators and pharmaceutical compositions containing thereof
11/24/2004	CN1549712A Antitumor agents and process for producing the same
11/24/2004	CN1549708A Anti-influenza agent
11/24/2004	CN1549705A Extended release oral dosage form
11/24/2004	CN1549704A Stabilized oral suspension formulation
11/24/2004	CN1548530A Interaction and influence on proliferation of neure cell of BEX1, LMO2 and SNF5
11/24/2004	CN1548436A Novel 2-alkyl substituted imidazole compounds
11/24/2004	CN1548423A Application of bisbenzylisoquinoline-(7-0-11')-single ether bond alkaloid derivative and analog in treating fibrosis related diseases
11/24/2004	CN1548143A Antifatigue Chinese medicine composition and its prepn process
11/24/2004	CN1548126A Brain nourishing health article
11/24/2004	CN1177046C Enhanced virus-mediated DNA transfer
11/24/2004	CN1177043C Acidophilic thermostable mycose-base synthetase and its prepn and use
11/24/2004	CN1176941C Caspase inhibitors and the use thereof
11/24/2004	CN1176915C Alkynyl phenyl heteroaromatic glucokinase activators
11/24/2004	CN1176911C Benzidine-sulfuryl radical substitution pentatomic heterocycle, its preparation method, its medicinal and composition
11/24/2004	CN1176910C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
11/24/2004	CN1176903C Method for synthesis of N-[(S)-1-carboxybutyl]-(S)-alanine esters and use in synthesis of perindoprill
11/24/2004	CN1176720C Hyacinth bletilla micro-balls for liver and kidney arterial embolism
11/24/2004	CN1176697C Antisenility medicine composition and its prepn
11/24/2004	CN1176694C Fatigue-resisting health food
11/24/2004	CN1176687C Medicine for strengthening intelligence and delaying senility and its prepn
11/24/2004	CN1176681C Chinese medicine compound preparation for comprehensively conditioning functions of human body and its preparing process
11/23/2004	US6822120 Sulfone liver X-receptor modulators
11/23/2004	US6822102 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of COX-2 mediated disorders
11/23/2004	US6822100 Reacting n-sulfonyl-3-vinylindole with ruthenium complex in presence of ethyl diazoacetate and toluene; psychological, sexual, and eating disorders
11/23/2004	US6822097 Compounds and methods of uses
11/23/2004	US6821989 Using a tamoxifen type compound
11/23/2004	US6821986 Drugs such as (2s)-2-amino-n-(4-anilinophenyl)-5-((imino(2-oxido-2 -oxohydrazino)methyl)amino) pentanamide, used as nitric oxide synthase inhibitors, free radical scavangers or as antioxidants
11/23/2004	US6821984 Ring fused pyrazole derivatives as CRF antagonists
11/23/2004	US6821980 Substituted 5-benzyl-2,4-diaminopyrimidines
11/23/2004	US6821978 Xanthine phosphodiesterase V inhibitors
11/23/2004	US6821977 Antidiabetic agents
11/23/2004	US6821974 Vasodilation; hypotensive agents; cardiovascular disorders
11/23/2004	US6821973 Compounds
11/23/2004	US6821971 For prophyalxis of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease (ibs), septic shock, cardiopulmonary dysfunction, acute respiratory disease, cachexia
11/23/2004	US6821970 Useful for treating diseases wherein modulation of 5-ht activity is desired; nervous system disorders
11/23/2004	US6821966 Antiinflammatory agents
11/23/2004	US6821965 Important in disease or medical conditions such as inflammation and immunoregulation
11/23/2004	US6821964 For prophylaxis and therapy of diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation
11/23/2004	US6821962 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and /or p56lck tyrosine kinases
11/23/2004	CA2332087C Aryl substituted azabenzimidazoles and their use in the treatment of hiv and aids related diseases
11/23/2004	CA2329788C Quinoline derivatives
11/23/2004	CA2326970C Acetylene derivatives as anti-inflammatory/analgesic agents
11/23/2004	CA2171446C Pseudo- and non-peptide bradykinin receptor antagonists
11/23/2004	CA2171329C Androstenones
11/23/2004	CA2161346C Sulfonamides and derivatives thereof that modulate the activity of endothelin
11/23/2004	CA2135768C Indolocarbazole imides and the use thereof
11/23/2004	CA2134239C Pretargeting methods and compounds
11/23/2004	CA2125288C Serotoninergic ergoline derivatives
11/23/2004	CA2111662C Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease

1 ... 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 ... 1564